CMO

PAN Finance Names Libertex ‘Global CFD Broker of the Year’

Retrieved on: 
Friday, March 29, 2024
Other Professional Services, Cryptocurrency, Finance, Banking, Professional Services, Technology, Fintech, Other Technology, Online, UN, Contract for difference, Editorial, FC Bayern, Republic, Risk, Philosophy, Partnership, Research, Stripe, Financial Services Commission, Date, Ecosystem, HSBC, Ban, CMO, Multimedia, ETF, MAEX, CFD, Financial adviser

The established global financial publication PAN Finance has determined Libertex to be the ‘CFD Broker of the Year – Global 2024’ following a rigorous evaluation process conducted by the publication's highly experienced editorial and research teams.

Key Points: 
  • The established global financial publication PAN Finance has determined Libertex to be the ‘CFD Broker of the Year – Global 2024’ following a rigorous evaluation process conducted by the publication's highly experienced editorial and research teams.
  • As an organisation, PAN Finance is committed to providing concise, intelligent, and up-to-date news for a worldwide readership of specialists spanning the entire finance industry.
  • Throughout the rest of 2024 and beyond, Libertex will continue to work hard to provide a CFD trading service worthy of "Broker of the Year".
  • Over the years, Libertex has received multiple prestigious international awards and recognitions, including "CFD Broker of the Year - Global" (PAN Finance Awards, 2024), "Best Trading Experience" (Ultimate Fintech Awards, 2023) and "Best CFD Broker" (World Finance Forex Awards, 2023).

Wildix Announces Entry into Saudi Arabia with AlJammaz Technologies Partnership

Retrieved on: 
Thursday, March 28, 2024
Technology, Mobile, Wireless, Carriers and Services, Telecommunications, Business, Professional Services, Audio, Video, Hardware, VoIP, Communication, Partnership, UC, KSA, GCC, Heart, Unified communications, CMO, Marketing, NTP, Gulf Cooperation Council

Wildix, a global innovator and leader in UC&C, today announced a strategic partnership with AlJammaz Technologies, marking a significant milestone in Wildix's global expansion.

Key Points: 
  • Wildix, a global innovator and leader in UC&C, today announced a strategic partnership with AlJammaz Technologies, marking a significant milestone in Wildix's global expansion.
  • By blending Wildix's innovative UC solutions with AlJammaz Technologies' expertise, this partnership is set to revolutionize business communications in Saudi Arabia.
  • “We are particularly proud of our new partnership with AlJammaz Technologies, a milestone that benefits us both enormously,” said Emiliano Tomasoni, CMO, Wildix.
  • “We are proud to partner with Wildix, an industry-leading player in the UC&C space,” said Adel Qahwash, General Manager, AlJammaz Technologies.

Osivax Announces Vaccination of Last Patient in Phase 2a Clinical Trial Evaluating OVX836 Combined with QIVs

Retrieved on: 
Tuesday, March 26, 2024
Research, Infectious Diseases, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Other Science, Science, Virus, Volunteering, Injection, Safety, CMO, Vaccine

Osivax , a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating viruses, today announced that all participants have completed their final visit in the Phase 2a clinical trial ( NCT05734040 ) evaluating OVX836, Osivax’ broad-spectrum influenza A vaccine candidate, in combination with Quadrivalent Influenza Vaccines (QIVs).

Key Points: 
  • Osivax , a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating viruses, today announced that all participants have completed their final visit in the Phase 2a clinical trial ( NCT05734040 ) evaluating OVX836, Osivax’ broad-spectrum influenza A vaccine candidate, in combination with Quadrivalent Influenza Vaccines (QIVs).
  • The randomized, double-blind, double placebo-controlled, parallel-group, multicentric clinical trial evaluated the safety and immunogenicity of a 480μg dose of the OVX836 vaccine with licensed QIVs and placebo in healthy participants across Australia.
  • “The data gathered from this Phase 2a trial is a necessary step in demonstrating OVX836’s ability to provide long-lasting, improved protection in combination with QIVs.
  • “The data collected from this trial will bolster our development of OVX836 as a broad-spectrum influenza vaccine.”

Elevating Societal Impact: Matter’s Precision Group Expands Client Base in Sustainability and Nonprofit Categories

Retrieved on: 
Tuesday, March 26, 2024
Software, Media, Philanthropy, Sustainability, Technology, Environment, Public Relations, Investor Relations, Green Technology, Marketing, Advertising, Content Marketing, Communications, Other Philanthropy, PR, Organization, Growth, Communication, Matter, Precision, CMO, Multimedia

Matter Communications – a Brand Elevation Agency integrating PR, marketing and creative services – today announced the growth of its Precision group, a PR and content division of Matter that provides highly focused programs to support brands’ biggest business drivers, in sustainability/Greentech and nonprofit categories.

Key Points: 
  • Matter Communications – a Brand Elevation Agency integrating PR, marketing and creative services – today announced the growth of its Precision group, a PR and content division of Matter that provides highly focused programs to support brands’ biggest business drivers, in sustainability/Greentech and nonprofit categories.
  • The concerted efforts of the team represent the agency’s commitment to serving the missions of brands that actively seek to improve communities, causes and the environment of the world around us.
  • “We see the Precision team at Matter as an extension of our internal team, helping to elevate our company in key trade, business and regional media.
  • This is why Precision was built!”
    To learn more about Matter’s Precision group, please visit the Matter Precision Page .

Chegg Appoints Deena Bahri as Chief Marketing Officer

Retrieved on: 
Wednesday, March 27, 2024
Software, Internet, Artificial Intelligence, Continuing, Technology, University, Education, Training, Adweek, Swarthmore College, Learning, Business administration, Triple accreditation, Harvard Business School, Textbook, Student, Woman, CHGG, Birchbox, Retirement, CMO, Multimedia, Management

Chegg, Inc. (NYSE: CHGG), the leading student-first connected learning platform, today announced the appointment of Deena Bahri as Chief Marketing Officer, effective March 27, 2024.

Key Points: 
  • Chegg, Inc. (NYSE: CHGG), the leading student-first connected learning platform, today announced the appointment of Deena Bahri as Chief Marketing Officer, effective March 27, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240326056340/en/
    During her 20-year career, Ms. Bahri has held key marketing positions at innovative tech-driven brands including Birchbox, Gilt Groupe, and Reebok.
  • She was most recently Chief Marketing Officer of leading current culture marketplace StockX, where she led the global marketing and merchandising teams.
  • Ms. Bahri will drive Chegg’s brand and user growth strategy as it delivers on its mission to empower learners worldwide through AI-powered personalized learning.

Trust & Will Helps You ‘Make It Count’ in New TV Campaign

Retrieved on: 
Monday, March 25, 2024
Electronic Commerce, Seniors, Technology, Managed Care, Family, TV and Radio, Consumer, Personal Finance, Other Professional Services, Parenting, Legal, Entertainment, Public Relations, Investor Relations, Marketing, Advertising, Communications, Media, Professional Services, Health, Other Consumer, CMO, Trust, SVP, Multimedia, Light, Growth, Parental leave

View the full release here: https://www.businesswire.com/news/home/20240325085778/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240325085778/en/
    Founded in 2017, Trust & Will is on a mission to help every family leave a legacy by bringing the estate planning process online.
  • Working with Marketing Architects to uncover audience insights and produce compelling creative, Trust & Will landed on ‘Make It Count’ for the campaign.
  • The campaign will run on both linear and streaming TV for maximum reach.
  • “We're excited about Trust & Will further tapping into TV’s ability to drive brand growth and help more people than ever in the estate planning process.”

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors

Retrieved on: 
Tuesday, March 26, 2024
General Health, Professional Services, Venture Capital, Medical Devices, Hospitals, Small Business, Clinical Trials, Cardiology, Biotechnology, Finance, FDA, Health, Brain, Boston Scientific, Growth, Aortic stenosis, Trust, Risk, Patient, Pivotal trial, Research, IDE, Doctor of Philosophy, Stanford University, CMO

Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a € 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816).

Key Points: 
  • Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a € 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816).
  • The funding round was structured in two separate capital increases which have both been completed.
  • It was co-led by a European consortium of VC investors including Sweden-based Segulah Medical Acceleration, Italy-based XGEN Venture, and Germany-based TechVision Fund.
  • Other investors include Coparion, several large family offices, angel investors and a multinational medical device strategic.

Arkose Labs taps Security Industry Veteran Patrick Kehoe as Chief Marketing Officer

Retrieved on: 
Thursday, March 21, 2024
Technology, Security, Fintech, Other Technology, Professional Services, Internet, Data Management, Retail, Artificial Intelligence, Online Retail, Invention, Thought, CMO, Multimedia, TIME, Growth, AI, Digital, Management

Arkose Labs , the global leader in bot management and account security, today announced the appointment of Patrick Kehoe to CMO.

Key Points: 
  • Arkose Labs , the global leader in bot management and account security, today announced the appointment of Patrick Kehoe to CMO.
  • In this role, Kehoe will oversee the strategic direction of the brand, content marketing, demand generation, product marketing, and digital marketing.
  • View the full release here: https://www.businesswire.com/news/home/20240321612523/en/
    Security Industry Veteran Patrick Kehoe joins Arkose Labs as Chief Marketing Officer (Photo: Business Wire)
    Kehoe joins Arkose Labs at a banner time.
  • Prior to joining Arkose Labs, Kehoe was CMO at Coalfire, a global risk management and compliance firm, and Axan, now Digital.AI, driving growth and shareholder value for each.

ON24 Empowers Enterprises to Accelerate Pipeline through Calendly Integration

Retrieved on: 
Wednesday, March 20, 2024
Technology, Marketing, Communications, Software, Internet, Digital Marketing, Data Management, Search Engine Marketing, Artificial Intelligence, CMO, Organization, ON24, Gartner, Sales

To help organizations stay ahead of this trend, ON24 (NYSE: ONTF), an intelligent engagement platform for B2B sales and marketing, announced an integration with Calendly, the platform helping individuals, teams, and organizations automate the meeting lifecycle.

Key Points: 
  • To help organizations stay ahead of this trend, ON24 (NYSE: ONTF), an intelligent engagement platform for B2B sales and marketing, announced an integration with Calendly, the platform helping individuals, teams, and organizations automate the meeting lifecycle.
  • Now, ON24 customers can seamlessly schedule sales meetings across digital experiences to increase conversion rates, accelerate pipeline and drive cost-effective revenue growth.
  • Improve efficiency and save time with streamlined workflows: Automatically pass attendee contact information to Calendly to facilitate a frictionless buying journey and unified data analytics.
  • “Digital-first marketing strategies are essential for reaching today’s customers where they are,” said Jessica Gilmartin, CRO at Calendly.

Industry Veteran Jeremy Johnson Joins CLARA Analytics Board

Retrieved on: 
Wednesday, March 20, 2024
Technology, Insurance, Professional Services, Health Insurance, Software, Health, Data Analytics, Data Management, Artificial Intelligence, Progressive Corporation, Fintech, ROI, Conference, Database, AIG, History, Artificial intelligence, Sale, Lexington Insurance Company, Roger Hawkins (drummer), P&C, University of Oxford, CMO, Management

CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced it has appointed Jeremy Johnson , former CEO of Protective Insurance, to its board of directors.

Key Points: 
  • CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for insurance claims optimization, today announced it has appointed Jeremy Johnson , former CEO of Protective Insurance, to its board of directors.
  • Johnson will further bolster the company’s deep bench of industry veterans, solidifying CLARA’s position as the leading innovator in AI technology for commercial claims management.
  • “CLARA’s platform represents a pivotal advancement for the P&C industry, and as a former CEO, it’s something I would have eagerly embraced,” expressed Johnson.
  • CLARA Analytics is a silver sponsor of the fifth annual InsurTech NY Conference , being held March 20-21, 2024, in New York City.